메뉴 건너뛰기




Volumn 121, Issue 5 SUPPL., 2002, Pages 197S-200S

5-Lipoxygenase inhibitors for the treatment of COPD

Author keywords

5 lipoxygenase; 5 lipoxygenase inhibitor; Antagonist; COPD; Leukotriene; Leukotriene B4; Neutrophil

Indexed keywords

2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CELL NUCLEUS RECEPTOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; PLACEBO; POBILUKAST; PROSTAGLANDIN SYNTHASE INHIBITOR; SB 201146; ZK 151657; ZK 158252; ZK 183838;

EID: 0036257558     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.5_suppl.197S     Document Type: Conference Paper
Times cited : (44)

References (15)
  • 12
    • 0035809314 scopus 로고    scopus 로고
    • High constitutive glucocorticoid receptor-α in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids
    • (2001) J Exp Med , vol.193 , pp. 585-594
    • Strickland, I.1    Kisich, K.2    Hauk, P.J.3
  • 14
    • 0030589226 scopus 로고    scopus 로고
    • Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities
    • (1996) J Immunol , vol.157 , pp. 5221-5224
    • Bailie, M.B.1    Standiford, T.J.2    Laichalk, L.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.